Elite AF IDE Trial (Elite AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT07287436

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07287436
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07287436. Allocation not applicable; no masking; primary purpose prevention. Start 2026-09-18 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Elite AF IDE Trial (Elite AF)
Condition
Atrial Fibrillation (AF)
Condition
Stroke
Intervention (Device)
WATCHMAN Elite LAAC Device
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct07287436
Content hash
f0be28d11348080d10dbcf3b22f3a1b0659c5fd42e99def733e499b3ebb081f1